Tag: Binnopharm

Binnopharm is a pharmaceutical company that operates two advanced GMP-compliant pharmaceutical plants. Binnopharm produces six dosage forms: ampoules, syringes, aerosols, pills, capsules and solutions. Binnopharm develops and manufactures drugs for the treatment of socially important diseases (respiratory diseases, pulmonology, neurology, nephrology, infectious diseases). Company comprises one of the largest full-cycle biopharmaceutical facilities in Russia with an area of 32,000 sq m; LLC Alium, a modern plant producing infusion solutions; and Binnopharm Distribution an in-house distributor of medicines produced both by Binnopharm/Alium and by third parties.
Company is developing original combinations, biosimilar drugs and unique medications belonging to different treatment groups: pulmonology, neurology, cardiology, gastroenterology and endocrinology. Binnopharm has the largest GMP facilities in Russia for the production of vaccines in ampoules (up to 80m ampoules per year) and a unique, fully equipped quality control laboratory. Over the past seven years, Binnopharm has been covering the bulk of the Russian state’s demand for Hepatitis B vaccine.
The company employs over 300 people, including an R&D group and a marketing and sales team, which were formed in 2015-2016.

Binnopharm can have tax benefits after receiving the status of industrial complex

binnopharm
30 industrial complexes and 31 industrial parks employing 79.6 thousand persons operate today in Moscow.

Binnopharm production facilities acquired the status of industrial complex

binnopharm
This will allow the company to receive tax preferences and other benefits, including reduced rates of profit tax, preferential rate of land lease and others.

Binnopharm and Biocom to receive loans from Russian Industrial Development Fund

pharm-manufacturing
Binnopharm will manufacture AERUS, an antiretroviral OTC drug in aerosol form, in Zelenograd

Nacimbio and Binnopharm will jointly develop and manufacture medicinal products

binnofarm-nacimbio
National Immunobiological Company, a part of Rostec Corporation, and Binnopharm, a Russian full-cycle pharmaceutical company owned by AFK Sistema, signed an agreement on cooperation

Binnopharm has become the exclusive representative of the German MEDICE

JSC Binnopharm, a Russian full-cycle pharmaceutical company, owned by AFK Sistema, has signed a licensing agreement with MEDICE Arzneimittel Pütter GmbH & Co. KG, ranked among top 15 German manufa...

JSC Binnopharm announces the acquisition of 100% stake of Alpharm LLC

JSC Binnopharm, a Russian full-cycle pharmaceutical company owned by AFK Sistema announces signing an agreement for purchase of 100 % of shares of Alpharm LLC and entering the market of OTC drugs. ...

Binnopharm industrial complex obtained ISO 9001:2015 certificate

The industrial complex Binnopharm has been certified for compliance with the latest version of GOST R ISO 9001: 2015 "Quality Management Systems. Requirements”. This GOST, which entered into force ...